Picture of Lucira Health logo

LHDXQ — Lucira Health News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Lucira Health: Rises as COVID-19 self-test kit becomes available on Amazon

** Shares of medical technology company  LHDX.O  up as much
as 10.81% at $5.64 premarket 
    ** Co's COVID-19 self-test kit is now available on Amazon
 urn:newsml:reuters.com:*:nBw8552dJa
    ** Co says kit provides a PCR quality test result at home in
30 minutes or less, after which the users receive a free, text
based verified test result on their phone for work or travel 
    ** The product costs $55 and includes free standard
shipping- LHDX
    ** The test kit fits in the palm of a hand, extracts genetic
material from the virus and amplifies it similar to PCR lab
tests 
    ** Co's shares rose as much as ~15% on April 9 after its
molecular test kit showed it can identify the "double mutant"
variant of COVID-19  urn:newsml:reuters.com:*:nL4N2M22RW

 (Reporting by Rithika Krishna in Bengaluru)
 ((Rithika.Krishna@thomsonreuters.com;))

Recent news on Lucira Health

See all news